Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
110 pending office actions • 60 clients • 107 examiners • 64 art units • 0 of 110 (0%) have an AI response strategy ready
BROWN RUDNICK LLP has a significant practice in the Biotechnology & Pharmaceuticals technology area. The firm has managed 4215 career applications. There are 88 pending office actions currently being prosecuted by the firm.
The firm's resolved allowance rate is 83.43 percent. This is achieved with an average of 3.89 office actions per allowance. This average reflects the typical complexity of biotechnology and pharmaceutical prosecution, which often requires multiple rounds of negotiation with the USPTO. The 83.43 percent allowance rate shows a high level of success in these challenging fields. With 88 pending actions, the firm maintains a substantial active docket. Practitioners can interpret the 3.89 average office actions as an indicator of the persistence required to navigate the examination process. The 4215 career applications demonstrate the firm's extensive experience in the life sciences sector.
Based on the USPTO statutory response window for each pending office action. 46 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 46 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 3 (3%) |
| §101 + other | 11 (10%) |
| §103 only | 28 (25%) |
| §102 only | 7 (6%) |
| §112 only | 10 (9%) |
| Double-patenting only | 2 (2%) |
| Double-patenting + other | 10 (9%) |
| Multi-statute (no §101) | 38 (35%) |
| No statute on record | 1 (1%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GIULIANI, THOMAS ANTHONY | 2 | 76.5% | +37.3% |
| CELESTINE, NYROBI I | 2 | 81.4% | +23.1% |
| SHAFQAT, AMY JEANETTE | 2 | 52.0% | +55.3% |
| EL-HAGE HASSAN, ABDALLAH A | 1 | 42.9% | +40.4% |
| MIANO, JOSEPH PAUL | 1 | 36.0% | +63.3% |
| PARSLEY, DAVID J | 1 | 54.0% | +28.7% |
| UBER, NATHAN C | 1 | 3.4% | +5.5% |
| SELLS, JAMES D | 1 | 81.4% | +11.9% |
| COLLARD JR, DWANE EDWARD | 1 | 0.0% | +0.0% |
| ALTER MORSCHAUSER, ALYSSA MARGO | 1 | 76.5% | +15.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18763063 | SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION | CELESTINE, NYROBI I | 3d overdue |
| 19075578 | SYSTEMS AND METHODS FOR PRINTING AND APPLYING LABELS | SELLS, JAMES D | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18104364 | Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase | ANDERSON, REBECCA L | 132d overdue |
| 18931823 | SYSTEMS AND METHODS FOR PROVIDING PERSONALIZED HEALTH RISK ASSESSMENTS AND RECOMMENDATIONS | HANKS, BENJAMIN L | 103d overdue |
| 18667133 | BIN OUTPUT EXPANDER DEVICES, SYSTEMS, AND METHODS | DEVINE, MOLLY K | 86d overdue |
| 17614826 | METHODS OF ALTERING CARDIAC REMODELING USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION | NESTOR, DONNA MICHELLE | 74d overdue |
| 18382772 | BENDING THE PROBES OF DEPTH GAUGES | COLEY, ZADE JAMES | 56d overdue |
| 17609114 | INTEGRATED MICROFLUIDIC PROBE (IMFP) AND METHODS OF USE THEREOF | LOGIE, MICHAEL J | 51d overdue |
| 18157616 | T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS | VIJAYARAGHAVAN, JAGAMYA NMN | 49d overdue |
| 18427093 | PROSTATE MEASUREMENT SYSTEM | SHAH, JAY B | 45d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19186177 | SHELLFISH SHUCKING KNIFE | PARSLEY, DAVID J | 78d overdue |
| 17495150 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | SHAFQAT, AMY JEANETTE | 43d overdue |
| 18763063 | SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION | CELESTINE, NYROBI I | 3d overdue |
| 19184676 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL NEUROMODULATION | GIULIANI, THOMAS ANTHONY | 12d |
| 17495144 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | SHAFQAT, AMY JEANETTE | 12d |
| 18030346 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | GIULIANI, THOMAS ANTHONY | 14d |
| 18763091 | SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING | CELESTINE, NYROBI I | 41d |
| 19232420 | DOUBLE BLIND WINE TASTING | EL-HAGE HASSAN, ABDALLAH A | — |
| Art Unit | Apps |
|---|---|
| 3794 | 5 |
| 3798 | 4 |
| 3791 | 3 |
| 1626 | 3 |
| 1629 | 2 |
| 1691 | 2 |
| 1632 | 2 |
| 3775 | 2 |
| 2881 | 2 |
| 1658 | 2 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19232420 | DOUBLE BLIND WINE TASTING | Cliink LLC | EL-HAGE HASSAN, ABDALLAH A | §101 | Non-Final OA | — | Pending | Jun 09, 2025 | |
| 19214187 | MAGNETIC CAPTURE DEVICE | Lo Biosciences, Inc. | MIANO, JOSEPH PAUL | 1631 | §103DP | Non-Final OA | — | Pending | May 21, 2025 |
| 19186177 | SHELLFISH SHUCKING KNIFE | Coastal Creative LLC | PARSLEY, DAVID J | 3643 | §103 | Final Rejection | 78d overdue | Pending | Apr 22, 2025 |
| 19184676 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL NEUROMODULATION | Neurent Medical Limited | GIULIANI, THOMAS ANTHONY | 3794 | §103§112 | Final Rejection | 12d | Pending | Apr 21, 2025 |
| 19184746 | LAND ACQUISITION AND PROPERTY DEVELOPMENT ANALYSIS PLATFORM | Landclan Limited | UBER, NATHAN C | 3626 | §101§102 | Non-Final OA | — | Pending | Apr 21, 2025 |
| 19075578 | SYSTEMS AND METHODS FOR PRINTING AND APPLYING LABELS | DMT SOLUTIONS GLOBAL CORPORATION | SELLS, JAMES D | §103 | Non-Final OA | — | Pending | Mar 10, 2025 | |
| 19066714 | SIMULTANEOUS MULTI-SITE VAGUS NERVE NEUROMODULATION FOR IMPROVED GLYCEMIC CONTROL SYSTEM AND METHODS | Reshape Lifesciences, Inc. | COLLARD JR, DWANE EDWARD | §102§103§112 | Non-Final OA | — | Pending | Feb 28, 2025 | |
| 19061441 | DEVICES AND METHODS FOR TREATING EDEMA | White Swell Medical Ltd. | ALTER MORSCHAUSER, ALYSSA MARGO | §102§103§112Other | Non-Final OA | — | Pending | Feb 24, 2025 | |
| 19042314 | DEVICES, SYSTEMS, AND METHODS FOR PROVIDING SECURE BRANCH-FREE PASSWORD AUTHENTICATION | Tropic Square S.R.O | POTRATZ, DANIEL B | 2491 | §112 | Non-Final OA | — | Pending | Jan 31, 2025 |
| 19029407 | SINGLE-PIECE HINGED CLAMP FOR TRACK MOUNTING ASSEMBLIES | Sunrun, Inc. | MINTZ, RODNEY K | 3635 | §112Other | Non-Final OA | — | Pending | Jan 17, 2025 |
| 19021430 | LYOPHILIZED FORMULATIONS OF TEGAVIVINT | Iterion Therapeutics, Inc. | TCHERKASSKAYA, OLGA V | §101§112Other | Non-Final OA | — | Pending | Jan 15, 2025 | |
| 18877731 | NEUROMODULATION OF TWO OR MORE NEURONAL TARGETS IN TREATMENT OF A MEDICAL CONDITION | Reshape Lifesciences, Inc. | TEHRANI, DANIEL | §102§103 | Final Rejection | — | Pending | Dec 20, 2024 | |
| 18984151 | VIRTUAL REALITY SURGICAL TRAINING SYSTEMS WITH ADVANCED HAPTIC FEEDBACK | Fvrvs Limited | GRANT, MICHAEL CHRISTOPHER | §101§102DP | Non-Final OA | — | Pending | Dec 17, 2024 | |
| 18976947 | RAPID LEACHING AND DEWATERING TECHNOLOGY (RLDT) FOR EX-SITU REMEDIATION OF PER- AND POLYFLUOROALKYL SUBSTANCES (PFAS) AND OTHER CONTAMINANTS IN SOIL | Next Earth Environmental LLC, C/O Hrp Associates, Inc. | TOLEDO-DURAN, EDWIN J | 3678 | §103§112 | Non-Final OA | — | Pending | Dec 11, 2024 |
| 18972013 | TREATING CANCER WITH CAS ENDONUCLEASE COMPLEXES | Stitch Bio, LLC | MOLOYE, TITILAYO | §102§103§112 | Non-Final OA | — | Pending | Dec 06, 2024 | |
| 18964231 | AUTOMATED SKIN CLOSURE SYSTEM | Opus Ksd Inc. | IGBOKO, CHIMA U | §103 | Non-Final OA | — | Pending | Nov 29, 2024 | |
| 18958497 | MAILING OPTIMIZATION SYSTEMS AND METHODS | DMT SOLUTIONS GLOBAL CORPORATION | DULANEY, BENJAMIN O | §102§103 | Non-Final OA | — | Pending | Nov 25, 2024 | |
| 18944843 | DRUG-ELUTING SURGICAL ARTICLES AND METHODS OF USE THEREOF | Biosapien Inc. | CONIGLIO, AUDREA JUNE BUCKLEY | §103§112 | Non-Final OA | — | Pending | Nov 12, 2024 | |
| 18931823 | SYSTEMS AND METHODS FOR PROVIDING PERSONALIZED HEALTH RISK ASSESSMENTS AND RECOMMENDATIONS | Aktivolabs Pte. Ltd. | HANKS, BENJAMIN L | 3684 | §101§103 | Final Rejection | 103d overdue | Pending | Oct 30, 2024 |
| 18918921 | INTRAVASCULAR CATHETERS | White Swell Medical Ltd. | D ABREU, MICHAEL JOSEPH | §102 | Non-Final OA | — | Pending | Oct 17, 2024 | |
| 18907844 | SYSTEMS AND METHODS FOR CONDUCTING REACTIONS AND SCREENING FOR REACTION PRODUCTS | Purdue Research Foundation | WANG, JING | §112Other | Non-Final OA | — | Pending | Oct 07, 2024 | |
| 18884815 | IN VITRO ASSAY TO PREDICT CARDIOTOXICITY | Stemina Biomarker Discovery, Inc. | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
| 18830947 | SYSTEMS AND METHODS FOR TREATING PULMONARY EDEMA | White Swell Medical Ltd. | WIEST, PHILIP R | §101§102§103 | Final Rejection | — | Pending | Sep 11, 2024 | |
| 18825146 | SYSTEMS AND METHODS FOR TREATING HEADACHE DISORDERS | Neurent Medical Limited | BOCK, ABIGAIL MARIE | 3794 | §103 | Final Rejection | — | Pending | Sep 05, 2024 |
| 18823050 | STABLE POLYMORPHIC COMPOSITIONS OF BREQUINAR SODIUM AND METHODS OF USE AND MANUFACTURE THEREOF | Clear Creek Bio, Inc. | SHOWALTER, ALEXANDER KEITH | §103§112DP | Non-Final OA | — | Pending | Sep 03, 2024 | |
| 18816456 | DEVICE FOR THERAPEUTIC SINO-NASAL TREATMENT | Neurent Medical Limited | LEE, DAVINA EN-YIN | 3794 | §102§112 | Non-Final OA | — | Pending | Aug 27, 2024 |
| 18812194 | SECURING MEDICAL TUBING | Alera Medtech Inc. | OSINSKI, BRADLEY JAMES | §102§103§112 | Non-Final OA | — | Pending | Aug 22, 2024 | |
| 18804859 | FORMULATIONS OF DIHYDROKAEMPFEROL | Debut Biotechnology, Inc. | CHI, AMANDA LYNN | §102§103§112 | Non-Final OA | — | Pending | Aug 14, 2024 | |
| 18798181 | SYSTEMS AND METHODS FOR TRIAGING HIGH RISK MESSAGES | Crisis Text Line, Inc. | STARKS, WILBERT L | 2122 | §101 | Final Rejection | — | Pending | Aug 08, 2024 |
| 18833637 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation | BURKE, MATTHEW RYAN | 1619 | §103 | Non-Final OA | — | Pending | Jul 26, 2024 |
| 18786006 | STABLE ANHYDROUS DISINFECTANT CONCENTRATE FORMULATION AND METHOD OF MAKING THE SAME | One Home Brands, Inc. | ALAWADI, SARAH | §103 | Non-Final OA | — | Pending | Jul 26, 2024 | |
| 18783819 | METHODS OF SYNTHESIZING 2-[4-[(2,3,4-TRIMETHOXYPHENYL)METHYL] PIPERAZIN-1-YL]ETHYL PYRIDINE-3-CARBOXYLATE | Imbria Pharmaceuticals, Inc. | BRAM, STANLEY | §102§103§112DP | Non-Final OA | — | Pending | Jul 25, 2024 | |
| 18780727 | METHODS OF TREATING HEART FAILURE WITH HIBERNATING MYOCARDIUM USING MODIFIED FORMS OF TRIMETAZIDINE | Imbria Pharmaceuticals, Inc. | TRAN, ERIC | 1629 | Other | Non-Final OA | — | Pending | Jul 23, 2024 |
| 18778234 | RNA TARGET ENRICHMENT OR DEPLETION OF BIOLOGICAL SAMPLES | Altratech Limited | RILEY, JEZIA | §101§103§112Other | Non-Final OA | — | Pending | Jul 19, 2024 | |
| 18763063 | SYSTEMS AND METHODS FOR TISSUE ANALYSIS AND VISUALIZATION | Luma Vision Limited | CELESTINE, NYROBI I | 3798 | §103 | Final Rejection | 3d overdue | Pending | Jul 03, 2024 |
| 18763091 | SYSTEMS AND METHODS FOR EVENT-DRIVEN ULTRASOUND SAMPLING | Luma Vision Limited | CELESTINE, NYROBI I | 3798 | §102§103 | Non-Final OA | 41d | Pending | Jul 03, 2024 |
| 18724423 | METHODS FOR REDUCING NITROUS OXIDE PRODUCTION | Agresearch Limited | KRUSE, DAVID H | 1663 | §102§112DP | Final Rejection | — | Pending | Jun 26, 2024 |
| 18722956 | AUTOMATED ULTRASOUND IMAGING ANALYSIS AND FEEDBACK | Geonomy, Ltd. | KOETH, MICHELLE M | 2671 | §103 | Final Rejection | — | Pending | Jun 21, 2024 |
| 18746622 | DETECTING AN ANALYTE IN A MEDIUM | Orb Xyz, Inc. | GUNBERG, EDWIN C | 2884 | §102§103 | Non-Final OA | 35d | Pending | Jun 18, 2024 |
| 18680094 | FRAUD DETECTION AND PREVENTION SYSTEM | Brightwell Payments, Inc. | HILMANTEL, ADAM J | 3691 | §101§103§112 | Non-Final OA | 26d | Pending | May 31, 2024 |
| 18678100 | DEEP LEARNING DRIVEN ADAPTIVE OPTICS FOR SINGLE MOLECULE LOCALIZATION MICROSCOPY | Purdue Research Foundation | VARNDELL, ROSS E | 2674 | §103§112 | Final Rejection | — | Pending | May 30, 2024 |
| 18667133 | BIN OUTPUT EXPANDER DEVICES, SYSTEMS, AND METHODS | DMT SOLUTIONS GLOBAL CORPORATION | DEVINE, MOLLY K | 3653 | §102§103 | Final Rejection | 86d overdue | Pending | May 17, 2024 |
| 18638472 | CANNABIDIOLIC ACID COCRYSTALS | Manoira Corporation | BRADY, KRISTEN WEEKS | §102§103§112DP | Non-Final OA | — | Pending | Apr 17, 2024 | |
| 18624508 | METHODS OF TREATING HEART FAILURE WITH REDUCED EJECTION FRACTION USING MODIFIED FORMS OF TRIMETAZIDINE | Imbria Pharmaceuticals, Inc. | SHIAO, REI TSANG | 1691 | DP | Non-Final OA | — | Pending | Apr 02, 2024 |
| 18692014 | VIRUS COMPOSITIONS TO EFFICIENTLY TARGET THE NERVOUS SYSTEM AND THE LUNGS | Capsida Biotherapeutics, Inc. | BOESEN, AGNIESZKA | 1632 | §112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18605038 | DATA COMMUNICATIONS SYSTEMS AND METHODS | Glo-Cap LLC | WYLLIE, CHRISTOPHER T | 2465 | §102§103 | Non-Final OA | 30d | Pending | Mar 14, 2024 |
| 18685109 | PEPTIDE-HLA-B*35 Libraries, Associated Compositions, and Associated Methods of Use | 3T Biosciences, Inc. | RAYMONDA, MATTHEW HAROLD | §102§103§112DP | Non-Final OA | — | Pending | Feb 20, 2024 | |
| 18581879 | ON-PREMISES SMARTBOX | Pt Intermediate Holdings Iv, LLC | BROWN, VERNAL U | 2686 | §103 | Non-Final OA | 17d overdue | Pending | Feb 20, 2024 |
| 18436332 | DEVICES AND METHODS FOR TREATING EDEMA | White Swell Medical Ltd. | DOUBRAVA, JOHN A | §102§112 | Non-Final OA | — | Pending | Feb 08, 2024 | |
| 18427093 | PROSTATE MEASUREMENT SYSTEM | Medicametrix, Inc. | SHAH, JAY B | 3791 | §102§103§112 | Final Rejection | 45d overdue | Pending | Jan 30, 2024 |
| 18421550 | COMBINATION THERAPY FOR TREATMENT OF CANCER | Pmv Pharmaceuticals, Inc. | PUTTLITZ, KARL J | §103§112 | Non-Final OA | — | Pending | Jan 24, 2024 | |
| 18411217 | DEVICES FOR USE IN ROBOT-ASSISTED MEDICAL PROCEDURES | Edge Surgical, Inc. | SEVILLA, CHRISTIAN ANTHONY | 3775 | §102 | Non-Final OA | — | Pending | Jan 12, 2024 |
| 18519342 | MASS SPECTROMETRY ANALYSIS OF MICROORGANISMS IN SAMPLES | Purdue Research Foundation | KIPOUROS, HOLLY MICHAELA | 1799 | §103§112 | Final Rejection | — | Pending | Nov 27, 2023 |
| 18512306 | LRRK2 INHIBITORS AND USES THEREOF | Neuron23, Inc. | CHAO, ALLEN | 1622 | §102 | Non-Final OA | — | Pending | Nov 17, 2023 |
| 18388634 | UNMANNED FULLY AUTONOMOUS VENDING KIOSK | Pt Intermediate Holdings Iv, LLC | GLASS, RUSSELL S | 3627 | §103 | Final Rejection | — | Pending | Nov 10, 2023 |
| 18387648 | SYSTEMS AND METHODS FOR MAILSTREAM POSTAGE PRESERVATION | DMT SOLUTIONS GLOBAL CORPORATION | DETWEILER, JAMES M | 3621 | §103 | Final Rejection | 46d overdue | Pending | Nov 07, 2023 |
| 18289186 | MODEL OPTIMIZED DRUG AND DRUG COMBINATIONS FOR TREATING CANCERS | My Personal Therapeutics | BURKHART, MICHAEL D | 1638 | §102 | Non-Final OA | — | Pending | Nov 01, 2023 |
| 18288910 | RECOMBINANT AAVS FOR DELIVERY TO CENTRAL NERVOUS SYSTEM AND BRAIN VASCULATURE | California Institute Of Technology | BOWLES, DAVID PAUL | 1632 | §101§102§112DP | Non-Final OA | — | Pending | Oct 30, 2023 |
| 18382772 | BENDING THE PROBES OF DEPTH GAUGES | Edge Surgical, Inc. | COLEY, ZADE JAMES | 3775 | §102§103 | Final Rejection | 56d overdue | Pending | Oct 23, 2023 |
| 18287357 | MULTIPLEXED ELECTROSPRAY IONIZATION SOURCES USING ORTHOGONAL INJECTION INTO AN ELECTRODYNAMIC ION FUNNEL | Purdue Research Foundation | EINHORN, MICA JILLIAN | 2881 | §103 | Non-Final OA | 75d | Pending | Oct 18, 2023 |
| 18378963 | CELLULAR COMPOSITIONS DERIVED FROM DECEASED DONORS TO PROMOTE GRAFT TOLERANCE AND MANUFACTURE AND USES THEREOF | Medeor Therapeutics, Inc. | SKELDING, ZACHARY S | 1644 | §103Other | Non-Final OA | — | Pending | Oct 11, 2023 |
| 18554382 | WNT AGONISTS FOR PREVENTION OF CANCER | Academish Medisch Centrum | DAVIS, BRIAN J | 1614 | §103 | Non-Final OA | 70d | Pending | Oct 06, 2023 |
| 18375063 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. | FERGUSON, JALISA HOLMES | 1626 | §102 | Final Rejection | 92d overdue | Pending | Sep 29, 2023 |
| 18284407 | SELECTED AAV COMPOSITIONS HAVING PREFERRED BRAIN ENRICHMENT | Capsida, Inc. | BANERJEE, KOYELI | 1658 | §112 | Non-Final OA | 14d | Pending | Sep 27, 2023 |
| 18367728 | METHODS OF PRODUCING MIXED CHIMERISM AFTER A SOLID ORGAN TRANSPLANT | Medeor Therapeutics, Inc. | LEE, YIE CHIA | 1642 | §103Other | Non-Final OA | 6d | Pending | Sep 13, 2023 |
| 18218353 | REPURPOSING BEADS IN SAMPLE CLEANUP | Tecan Genomics, Inc. | ZHANG, KAIJIANG | §102Other | Non-Final OA | — | Pending | Jul 05, 2023 | |
| 18216185 | METHODS AND DEVICES FOR INTEGRATING PARCEL INFORMATION | Block X, Inc. | MOLNAR, HUNTER A | 3628 | §101§103§112 | Final Rejection | 7d | Pending | Jun 29, 2023 |
| 18341436 | COMPOSITIONS AND METHODS FOR IDENTIFICATION OF A DUPLICATE SEQUENCING READ | Tecan Genomics, Inc. | PHAM, KHAI QUYNH TIEN | 1684 | §102§103§112DP | Final Rejection | — | Pending | Jun 26, 2023 |
| 18203343 | System and Method for Improving Telematics Location Information and Reliability of E911 Calls | Sirius Xm Radio Inc. | AHSAN, UMAIR | 2647 | §103§112DP | Non-Final OA | — | Pending | May 30, 2023 |
| 18198538 | SYSTEMS AND METHODS FOR TISSUE EVALUATION AND CLASSIFICATION | Oneprojects Design And Innovation Ltd. | DRYDEN, EMMA ELIZABETH | 2677 | §103 | Final Rejection | 9d | Pending | May 17, 2023 |
| 18196142 | TRANSCATHETER VEIN FRAME FOR VENOUS INSUFFICIENCY | Envveno Medical Corporation | COCHRAN, KARI LEE | 3774 | §102§103 | Non-Final OA | — | Pending | May 11, 2023 |
| 18036549 | KINASE MODULATORS AND METHODS OF USE THEREOF | Neuron23, Inc. | MCDOWELL, BRIAN E | 1624 | §112 | Non-Final OA | 29d | Pending | May 11, 2023 |
| 18030346 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | Neurent Medical Limited | GIULIANI, THOMAS ANTHONY | 3794 | §102§112 | Non-Final OA | 14d | Pending | Apr 05, 2023 |
| 18025718 | INFUSION SITE RETAINER FOR MAINTAINING INFUSION TUBING | Medicametrix, Inc. | MEDWAY, SCOTT J | 3783 | §102§103 | Final Rejection | — | Pending | Mar 10, 2023 |
| 18177566 | COMPOSITIONS AND METHODS FOR CROSSING BLOOD BRAIN BARRIER | California Institute Of Technology | BORGEEST, CHRISTINA M | 1675 | §112 | Non-Final OA | 63d | Pending | Mar 02, 2023 |
| 18023675 | DEVICE FOR THERAPEUTIC SINO-NASAL TREATMENT | Neurent Medical Limited | RHODES, NORA W | 3794 | §103 | Non-Final OA | 15d overdue | Pending | Feb 27, 2023 |
| 18022056 | ADENO-ASSOCIATED VIRUS COMPOSITIONS HAVING PREFERRED EXPRESSION LEVELS | California Institute Of Technology | SIFFORD, JEFFREY MARK | 1671 | §103§112 | Non-Final OA | 13d | Pending | Feb 17, 2023 |
| 18104364 | Inhibitors of Rho Associated Coiled-Coil Containing Protein Kinase | Kadmon Corporation, LLC | ANDERSON, REBECCA L | 1626 | §102§103 | Final Rejection | 132d overdue | Pending | Feb 01, 2023 |
| 18157616 | T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS | 3T Biosciences, Inc. | VIJAYARAGHAVAN, JAGAMYA NMN | 1633 | §102§103§112 | Final Rejection | 49d overdue | Pending | Jan 20, 2023 |
| 18157618 | T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS | 3T Biosciences, Inc. | PAK, MICHAEL D | 1674 | §103§112 | Non-Final OA | — | Pending | Jan 20, 2023 |
| 18096685 | SYSTEMS AND METHODS FOR CREATING 3D OBJECTS | Fathom Manufacturing LLC | LOHARIKAR, ANAND R | 3689 | §101 | Non-Final OA | 10d overdue | Pending | Jan 13, 2023 |
| 17922890 | DOSING METHODS FOR TREATMENT OF CARDIOVASCULAR CONDITIONS | Imbria Pharmaceuticals, Inc. | FETTEROLF, BRANDON J | 1626 | DP | Non-Final OA | 53d overdue | Pending | Nov 02, 2022 |
| 17972972 | PLASTICIZERS TO IMPROVE RELEASE PERFORMANCE OF AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation | KAMM, JUDITH MARIE | 1611 | §103 | Final Rejection | 5d | Pending | Oct 25, 2022 |
| 17802873 | APPARATUS AND METHOD OF CONVERTING DIGITAL IMAGES TO THREE-DIMENSIONAL CONSTRUCTION IMAGES | Tailorbird, Inc. | BONANSINGA, AARON TIMOTHY | 2673 | §103 | Non-Final OA | 29d | Pending | Aug 26, 2022 |
| 17800993 | YEAST DISPLAY LIBRARIES, ASSOCIATED COMPOSITIONS, AND ASSOCIATE METHODS OF USE | 3T Biosciences, Inc. | ESPINOSA, CLAUDIA EDILMA | 1654 | §103DP | Final Rejection | 89d overdue | Pending | Aug 19, 2022 |
| 17885946 | CIRCADIAN SLEEP STAGING | Cerno Health Inc. | WELCH, HALLE MARGARET | 3796 | §101§102§103§112 | Non-Final OA | 7d | Pending | Aug 11, 2022 |
| 17720020 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. | PAK, YONG D | 1652 | §103 | Non-Final OA | — | Pending | Apr 13, 2022 |
| 17720006 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. | STEADMAN, DAVID J | 1656 | §103§112Other | Non-Final OA | 29d | Pending | Apr 13, 2022 |
| 17720036 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. | BREEN, KIMBERLY CATHERINE | 1657 | §103 | Non-Final OA | — | Pending | Apr 13, 2022 |
| 17720031 | FLAVONOID AND ANTHOCYANIN BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. | EPSTEIN, TODD MATTHEW | 1652 | §103§112Other | Final Rejection | 60d | Pending | Apr 13, 2022 |
| 17695073 | STRUCTURED SUBSTRATES FOR OPTICAL SURFACE PROFILING | Trustees Of Boston University | FLINDERS, JEREMY C | 1684 | §102Other | Non-Final OA | 7d | Pending | Mar 15, 2022 |
| 17690708 | DISPOSABLE CATHETER WITH ROTATABLE IMAGE ARRAY | Oneprojects Design And Innovation Ltd. | LANGHALS, RENEE C | 3797 | §103 | Final Rejection | — | Pending | Mar 09, 2022 |
| 17679568 | METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION | Pmv Pharmaceuticals, Inc. | JOHNSON, CHRISTOPHER LINDSAY | 1691 | §112Other | Non-Final OA | — | Pending | Feb 24, 2022 |
| 17614826 | METHODS OF ALTERING CARDIAC REMODELING USING COMPOUNDS THAT PROMOTE GLUCOSE OXIDATION | Imbria Pharmaceuticals, Inc. | NESTOR, DONNA MICHELLE | 1627 | §103§112 | Final Rejection | 74d overdue | Pending | Nov 29, 2021 |
| 17609114 | INTEGRATED MICROFLUIDIC PROBE (IMFP) AND METHODS OF USE THEREOF | Purdue Research Foundation | LOGIE, MICHAEL J | 2881 | §103§112 | Final Rejection | 51d overdue | Pending | Nov 05, 2021 |
| 17509535 | SYSTEMS AND METHODS FOR REDUCING PRESSURE AT AN OUTFLOW OF A DUCT | White Swell Medical Ltd. | NGO, MEAGAN N | 3781 | §103§112 | Final Rejection | — | Pending | Oct 25, 2021 |
| 17507607 | BIOPROSTHETIC GRAFT FOR CORONARY ARTERY BYPASS GRAFTING | Envveno Medical Corporation | TRAN, JULIE THI | 3791 | §103§112 | Non-Final OA | — | Pending | Oct 21, 2021 |
| 17604309 | METHODS AND SYSTEMS FOR NEURAL REGULATION | Reshape Lifesciences, Inc. | SCHMITT, BENJAMIN ALLYN | 3796 | §103 | Final Rejection | — | Pending | Oct 15, 2021 |
| 17495144 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | Neurent Medical Limited | SHAFQAT, AMY JEANETTE | 3798 | §103§112 | Non-Final OA | 12d | Pending | Oct 06, 2021 |
| 17495150 | SYSTEMS AND METHODS FOR THERAPEUTIC NASAL TREATMENT | Neurent Medical Limited | SHAFQAT, AMY JEANETTE | 3798 | §103§112 | Non-Final OA | 43d overdue | Pending | Oct 06, 2021 |
| 17480501 | CONTROLLING PROXIMITY OF IMMUNE CELL RECEPTORS | A2 Biotherapeutics, Inc. | TIWARI, VYOMA SHUBHAM | 1634 | §112 | Non-Final OA | 22d | Pending | Sep 21, 2021 |
| 17359714 | MODIFIED RELEASE FORMULATIONS OF MODIFIED FORMS OF TRIMETAZIDINE | Imbria Pharmaceuticals, Inc. | GONZALEZ, LUISALBERTO | 1624 | §103DP | Non-Final OA | 128d overdue | Pending | Jun 28, 2021 |
| 17348488 | METHODS AND COMPOUNDS FOR RESTORING MUTANT P53 FUNCTION | Pmv Pharmaceuticals, Inc. | ENGLISH, CONNOR KENNEDY | 1625 | §112 | Final Rejection | — | Pending | Jun 15, 2021 |
| 17341834 | NON-THROMBOGENIC DEVICES FOR TREATING EDEMA | White Swell Medical Ltd. | TRAN, THIEN JASON | 3792 | §103 | Final Rejection | — | Pending | Jun 08, 2021 |
| 17323683 | CBX8 CHROMDOMAIN INHIBITORS AND THE USES THEREOF | Purdue Research Foundation | NIEBAUER, RONALD T | 1658 | §103§112 | Non-Final OA | — | Pending | May 18, 2021 |
| 17289428 | An Intraurethral Magnetic Valve and Associated Parts | Ingenion Medical Limited | HONRATH, MARC D | 3791 | §103 | Non-Final OA | 49d overdue | Pending | Apr 28, 2021 |
| 17231224 | METHODS FOR ANALYZING A TISSUE SAMPLE | Purdue Research Foundation | SIMMONS, VALERIE MICHELLE | 1758 | §103 | Final Rejection | 34d | Pending | Apr 15, 2021 |
| 17081417 | COMPOSITIONS AND METHODS FOR TARGETED NUCLEIC ACID SEQUENCE ENRICHMENT AND HIGH EFFICIENCY LIBRARY GENERATION | Nugen Technologies, Inc. | BERTAGNA, ANGELA MARIE | 1681 | §103 | Final Rejection | 14d | Pending | Oct 27, 2020 |
| 17074914 | SYSTEMS AND METHODS FOR CELL CULTURING | Flaskworks, LLC | MOSS, NATALIE M | 1653 | §103§112 | Final Rejection | 36d overdue | Pending | Oct 20, 2020 |
| 16365074 | COMPOSITIONS AND METHODS FOR INCREASING EFFICIENCY OF CARDIAC METABOLISM | Imbria Pharmaceuticals, Inc. | NEAGU, IRINA | 1629 | §103 | Final Rejection | — | Pending | Mar 26, 2019 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial